http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0606883-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b29af93f8df5589977553870d06ef05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
filingDate 2006-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15da691e8bbeff0ddeb9db1bd29e0ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197682ebd2eaee599b21f25910914d3f
publicationDate 2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0606883-A2
titleOfInvention pharmaceutical composition for oral administration, method for preparing a tablet, and single solid dosage form
abstract PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, METHOD FOR PREPARING A TABLET, AND SINGLE SOLID DOSAGE FORM. A pharmaceutical composition for oral administration, comprising a fixed dose combination of a first solid pharmaceutical composition containing fenofibrate as the active substance and a second solid pharmaceutical composition containing an HMG-CoA reductase inhibitor such as a statin as the active substance. wherein the first and second pharmaceutical compositions are present in separate entities in a single solid dosage form. For example, a multilayer tablet, a bilayer tablet or capsule or sachet containing the active ingredients in granules or separate beads, granules or beads optionally being coated with a protective coating or an entero coating.
priorityDate 2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536034

Total number of triples: 26.